Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Inder Anand

Showing results (51-60 of 110) with videos related to

Pageof 11
Sort By:
Circulation|December 28, 2006
Effects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with New York Heart Association class IV heart failureJoAnn Lindenfeld, Arthur M Feldman, Leslie Saxon, et al.
Circulation|July 11, 2007
Prediction of mode of death in heart failure: the Seattle Heart Failure ModelDariush Mozaffarian, Stefan D Anker, Inder Anand, et al.
JACC. Asia|November 7, 2022
Prevalence and Prognostic Significance of Frailty in Asian Patients With Heart Failure: Insights From ASIAN-HFThan Aung, Yan Qin, Wan Ting Tay, et al.
Circulation|March 15, 2006
The Seattle Heart Failure Model: prediction of survival in heart failureWayne C Levy, Dariush Mozaffarian, David T Linker, et al.
Circulation|June 10, 2009
DITPA (3,5-Diiodothyropropionic Acid), a thyroid hormone analog to treat heart failure: phase II trial veterans affairs cooperative studySteven Goldman, Madeline McCarren, Eugene Morkin, et al.
JACC. Heart Failure|October 4, 2024
Natriuretic Peptides, Kidney Function, and Clinical Outcomes in Heart Failure With Preserved Ejection FractionBrendon L Neuen, Muthiah Vaduganathan, Brian L Claggett, et al.
Journal of the American Heart Association|December 20, 2019
Regional Variation of Mortality in Heart Failure With Reduced and Preserved Ejection Fraction Across Asia: Outcomes in the ASIAN-HF RegistryMichael R MacDonald, Wan Ting Tay, Tiew-Hwa Katherine Teng, et al.
Circulation|August 26, 2009
Maximizing survival benefit with primary prevention implantable cardioverter-defibrillator therapy in a heart failure populationWayne C Levy, Kerry L Lee, Anne S Hellkamp, et al.
JACC. Heart Failure|March 7, 2023
Comparison of Investigator-Reported and Centrally Adjudicated Heart Failure Outcomes in the EMPEROR-Reduced TrialPeter Carson, John R Teerlink, Michel Komajda, et al.
Circulation|April 28, 2017
Role of Biomarkers for the Prevention, Assessment, and Management of Heart Failure: A Scientific Statement From the American Heart AssociationSheryl L Chow, Alan S Maisel, Inder Anand, et al.
Pageof 11

Showing results (51-60 of 110) with videos related to

Sort By:
Pageof 11
Circulation|December 28, 2006
Effects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with New York Heart Association class IV heart failureJoAnn Lindenfeld, Arthur M Feldman, Leslie Saxon, et al.
Circulation|July 11, 2007
Prediction of mode of death in heart failure: the Seattle Heart Failure ModelDariush Mozaffarian, Stefan D Anker, Inder Anand, et al.
JACC. Asia|November 7, 2022
Prevalence and Prognostic Significance of Frailty in Asian Patients With Heart Failure: Insights From ASIAN-HFThan Aung, Yan Qin, Wan Ting Tay, et al.
Circulation|March 15, 2006
The Seattle Heart Failure Model: prediction of survival in heart failureWayne C Levy, Dariush Mozaffarian, David T Linker, et al.
Circulation|June 10, 2009
DITPA (3,5-Diiodothyropropionic Acid), a thyroid hormone analog to treat heart failure: phase II trial veterans affairs cooperative studySteven Goldman, Madeline McCarren, Eugene Morkin, et al.
JACC. Heart Failure|October 4, 2024
Natriuretic Peptides, Kidney Function, and Clinical Outcomes in Heart Failure With Preserved Ejection FractionBrendon L Neuen, Muthiah Vaduganathan, Brian L Claggett, et al.
Journal of the American Heart Association|December 20, 2019
Regional Variation of Mortality in Heart Failure With Reduced and Preserved Ejection Fraction Across Asia: Outcomes in the ASIAN-HF RegistryMichael R MacDonald, Wan Ting Tay, Tiew-Hwa Katherine Teng, et al.
Circulation|August 26, 2009
Maximizing survival benefit with primary prevention implantable cardioverter-defibrillator therapy in a heart failure populationWayne C Levy, Kerry L Lee, Anne S Hellkamp, et al.
JACC. Heart Failure|March 7, 2023
Comparison of Investigator-Reported and Centrally Adjudicated Heart Failure Outcomes in the EMPEROR-Reduced TrialPeter Carson, John R Teerlink, Michel Komajda, et al.
Circulation|April 28, 2017
Role of Biomarkers for the Prevention, Assessment, and Management of Heart Failure: A Scientific Statement From the American Heart AssociationSheryl L Chow, Alan S Maisel, Inder Anand, et al.
Pageof 11